/
Immunology
337Diseases↗
1.4KPipeline Programs↗
1.8KActive Trials↗
Momentum Score:100/100
Landscape
Disease Coverage Map
Bubble size = actively recruiting trials · Click to explore
Analysis
Phase Distribution
Analysis
Trial Status
8,461
clinical trials
Completed4,969 · 59%
Recruiting972 · 11%
Terminated746 · 9%
Unknown status601 · 7%
Not yet recruiting425 · 5%
Active, not recruiting392 · 5%
Other356 · 4%
Competitive
Top Companies Companies ranked by number of pipeline programs they run in this therapeutic area.
Landscape
Diseases
Systemic Lupus Erythematosus
Most programs123
Programs
1,247
Trials
80
Recruiting
Pre
27
P1
43
P2
25
P3
16
Appr
19
Most programs:
Pfizer
PfizerUlcerative Colitis
Most trials91
Programs
227
Trials
85
Recruiting
Pre
28
P1
8
P2
23
P3
15
Appr
22
Most programs:
Takeda
TakedaRheumatoid Arthritis
Highest activity132
Programs
177
Trials
75
Recruiting
Pre
66
P1
23
P2
20
P3
14
Appr
53
Most programs:Pfizer
PfizerAtopic Dermatitis
892 programs216 trialsApproved
Psoriasis
395 programs188 trialsApproved
Lupus
8 programs270 trialsApproved
Crohn's Disease
859 programs185 trialsApproved
Lupus Erythematosus
10 programs192 trialsApproved
Graft Versus Host Disease
259 programs116 trialsApproved
HAE
1 program160 trialsPhase 3
Myasthenia Gravis
41 programs93 trialsApproved
Systemic Sclerosis
46 programs73 trialsApproved
Moderate to Severe Atopic Dermatitis
4 programs98 trialsPhase 3
Immunodeficiency
253 programs46 trialsApproved
Allergic Rhinitis
245 programs51 trialsApproved
Psoriatic Arthritis
24 programs66 trialsApproved
Allergy
424 programs59 trialsApproved
Alopecia Areata
226 programs48 trialsApproved
Chronic Graft Versus Host Disease
323 programs46 trialsApproved
Vasculitis
28 programs40 trialsApproved
Mucositis
24 programs43 trialsApproved
Oral Mucositis
116 programs37 trialsApproved
Systemic Lupus Erythematosus (SLE)
39 programs38 trialsPhase 3
Angioedema
20 programs24 trialsApproved
Acute Graft Versus Host Disease
11 programs32 trialsApproved
Refractory Systemic Lupus Erythematosus
3 programs36 trialsPhase 1
Chronic Granulomatous Disease
219 programs16 trialsApproved
Autoimmune Hemolytic Anemia
1 program31 trialsPhase 1
Myositis
13 programs27 trialsApproved
Sjögren's Syndrome
4 programs23 trialsPhase 3
Showing top 30 diseases by activity. 307 more diseases in this therapeutic area.Activity = a momentum score from recent trial starts, number of sponsoring companies, and total trial volume.
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)